[ad_1]
Noemi Lukacs, a 71-year-old biologist, retired to Szirak, her hometown, to create English & Scientific Consulting (SciCons) and produce a genetic detector so sensitive that only a few grams of it can feed the entire industry. world for a year.
“We make monoclonal antibodies,” Lukacs told Reuters of the one-story house, now partially converted into a first-class laboratory. The white powder is delivered worldwide from this place, writes HotNews.
“These antibodies recognize ribonucleic acid,” he explained. Its presence signals the existence of a living virus. More importantly, it is a derivative of the process used by giant Pfizer and the German company BioNTech to create their experimental coronavirus vaccine. And because it can be harmful to human cells, it must be filtered out of any vaccine used in humans.
There are several filtration methods, but the most used for quality control is exposure of the vaccine to antibodies produced by Lukacs. The result: a queue of representatives of the main pharmaceutical companies at his door.
The small company is growing rapidly, but its revenues reached only 124 million forints (just over $ 400,000) last year, with profits of 52 million forints. The money goes to five employees and funds from local charity projects in Szirak.
Read the full story: A company from a Hungarian village plays a hugely important role in the race to get a COVID vaccine
Noemi Lukacs is satisfied. Success in his field is enough. The mRNA methodology represents an entirely new group of drugs, the COVID-19 vaccine is the first product that is likely to receive the green light and reach mass production.
READ ALSO:
Coronavirus Romania. List of the most severely affected areas in the country due to the epidemic. Alarming situation in Bucharest and in five counties
.
[ad_2]
Source link
